Search Results
Imugene Investor Webinar: MAST Study Update
Imugene Investor Webinar | Acquisition of License for Azer-Cel Cell Therapy
Imugene Investor Webinar | FDA IND Clearance for onCARlytics
Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24
'The Why' | Imugene, Developing Cancer Immunotherapies ASX: IMU
Imugene Investor Presentation | Non-deal Roadshow 2023 Australia
Imugene forges development path of immunotherapies and cancer-killing virus
A clinical stage immuno-oncology company.
Imugene welcomes positive FDA feedback on new manufacturing process for azer-cel
Interview With The CF33 Oncolytic Virus Inventor - Imugene (IMU)
First Patient dosed in Imugene's PD1-Vaxx Combination Trial
Imugene (ASX: IMU) Presentation | NWR Virtual Healthcare Conference
